CYP2B6

cytochrome P450 family 2 subfamily B member 6

Pharmacogene

Summary

This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008]

Known Variants88 total

rsidPosition (GRCh37)AllelesClassClinVar
rs3488343219:40,991,367A/Tmissense variantlikely benign
rs3397333719:40,991,381A/Tmissense variant
rs3398038519:40,991,388A/Gmissense variant
rs3392610419:40,991,390C/Amissense variant
rs3428477619:40,991,391G/Cmissense variant
rs3606084719:41,004,125G/Amissense variant
rs3577304019:41,004,381G/Amissense variantlikely benign
rs14588440219:41,004,406G/Tmissense variant
rs382671119:41,006,919C/Gmissense variant
rs3605653919:41,006,923C/Tmissense variant
rs4548260219:41,009,350C/Amissense variantlikely benign
rs13902962519:41,010,006G/Cmissense variant
rs3469875719:41,010,088C/Gmissense variant
rs19392291719:41,010,108C/Amissense variant
rs3482650319:41,012,339C/Tmissense variant
rs3597956619:41,012,693T/Amissense variant
rs19392291819:41,012,740G/Amissense variant
rs3501009819:41,012,803C/Amissense variant
rs321136919:41,016,726A/Gmissense variant
rs56408398919:41,016,778G/Amissense variant
rs480210119:41,496,461T/Cupstream gene variant
rs3422310419:41,497,129T/Cupstream gene variant
rs3447744519:41,497,256T/Clikely benign
rs15074242319:41,497,264C/Alikely benign
rs819270919:41,497,274C/Amissense variant
rs77150158219:41,497,340C/Guncertain significance
rs3530348419:41,497,346A/Gmissense variant
rs1040395519:41,509,438T/Gintron variant
rs28186490719:41,509,920T/Astop gaineddrug response
rs19970487219:41,509,936G/Auncertain significance
rs37229536019:41,510,027G/Auncertain significance
rs14800990619:41,510,038G/Tuncertain significance
rs143560187619:41,510,047G/Cuncertain significance
rs18633545319:41,510,063G/Tmissense variantdrug response
rs78009823019:41,510,066A/Guncertain significance
rs13980127619:41,510,208T/Cmissense variantdrug response
rs1272165519:41,510,282A/Gmissense variantlikely benign
rs77048345519:41,510,312G/Auncertain significance
rs77547313719:41,510,328T/Cuncertain significance
rs18304077819:41,510,339C/Tuncertain significance
rs138177382819:41,510,350G/Tuncertain significance
rs480341919:41,512,792C/Tintron variant
rs37381917119:41,512,815C/Tuncertain significance
rs374527419:41,512,841G/Tmissensedrug response
rs14058229019:41,512,848A/Guncertain significance
rs37348963719:41,512,873T/Gmissense variantdrug response
rs3607918619:41,512,918T/Cmissense variantdrug response
rs55816310019:41,512,944T/Cuncertain significance
rs37142491019:41,512,962T/Cmissense variantdrug response
rs1272164619:41,515,107C/Tintron variant
rs37635913419:41,515,192G/Alikely benign
rs3534998719:41,515,201C/Alikely benign
rs227934319:41,515,263A/Gmissensebenign
rs251618655319:41,515,267C/Auncertain significance
rs18997062319:41,515,273C/Tlikely benign
rs77349486719:41,515,275A/Tuncertain significance
rs227934419:41,515,483G/Aintron variant
rs227934519:41,515,702T/G
rs2839949919:41,515,810T/Cmissensedrug response
rs131597102919:41,515,957C/Tuncertain significance
rs37025150719:41,518,223G/Auncertain significance
rs75811090119:41,518,235G/Auncertain significance
rs56721932619:41,518,245G/Auncertain significance
rs55365883119:41,518,260A/Guncertain significance
rs56598064119:41,518,266G/Cuncertain significance
rs251619187819:41,518,281A/Guncertain significance
rs37502090919:41,518,319G/Auncertain significance
rs3409709319:41,518,370C/Tstop gaineddrug response
rs20045861419:41,518,371G/Auncertain significance
rs20033443719:41,518,399G/Alikely benign
rs3544927119:41,518,573C/Tlikely benign
rs196930423519:41,518,585G/Auncertain significance
rs214467723319:41,518,642G/Auncertain significance
rs3566188019:41,518,644C/Tlikely benign
rs124827145719:41,518,677T/Auncertain significance
rs86712667619:41,518,678G/Tuncertain significance
rs819271919:41,518,773C/A
rs480210419:41,521,527A/T
rs726032919:41,521,638G/T
rs810984819:41,522,069G/A
rs75878914519:41,522,575G/Tuncertain significance
rs14348841719:41,522,579C/Tlikely benign
rs14695637019:41,522,591A/Glikely benign
rs36853140219:41,522,642C/Tlikely benign
rs14741057819:41,522,670C/Tuncertain significance
rs321137119:41,522,715C/Tmissense
rs14852055419:41,522,728G/Auncertain significance
rs104238919:41,524,153T/C3 prime UTR variant

Gene information from NCBI Gene. Variant classifications from ClinVar.